Regulatory T Cell Dysfunction and Immunotherapeutic Breakthroughs in Type 1 Diabetes

    January 2026 in “ Frontiers in Endocrinology ”
    Kuang-Ji Zhou, S. S. Rong, Yue-Chen Liu … Cong-Yi Wang
    Studysummary This review discusses the impaired functionality of regulatory T cells in the pancreas during the development of Type 1 diabetes, highlighting their role in disease pathogenesis, potential of Treg-based therapies, and challenges in clinical applications.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on public-pages-files-2025.frontiersin.org →
    Discuss this study in the Community →